Biogen Inc. (IDP)
XDUS
Closed
Aug 25, 2026
Day's Range
184.9252 wk Range
112.95Overview - IDP - Biogen Inc.
Key Statistics
Valuation
P/E (Trailing)
‪21.46‬
PEG Ratio
‪-0.25‬
Price / Book
‪1.48‬
Profitability
Gross Margin
‪71.60%‬
Profit Margin
‪75.69%‬
Operating Margin
‪18.44%‬
Return on Assets
‪4.39%‬
Return on Equity
‪7.08%‬
Ownership
Shares Outstanding
147.70M
Price stats
50-Day Avg
‪178.74‬
200-Day Avg
‪162.35‬
Peers - IDP - Biogen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- IDPXDUSBiogen Inc.+36.31%52-week change20.87P/E (Trailing)‪75.69%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+43.59%52-week change17.50P/E (Trailing)‪74.80%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+42.98%52-week change-13.15P/E (Trailing)‪58.75%‬Profit Margin
- LLYXDUSEli Lilly and Company+41.57%52-week change46.30P/E (Trailing)‪83.04%‬Profit Margin
- JNJXDUSJohnson & Johnson+35.04%52-week change20.97P/E (Trailing)‪67.87%‬Profit Margin
- 7XPXDUSOrganon & Co.+32.30%52-week change16.31P/E (Trailing)‪53.29%‬Profit Margin
- JNJ0XDUSJohnson & Johnson CDR+31.37%52-week change18.85P/E (Trailing)‪67.87%‬Profit Margin
Profile Summary - IDP - Biogen Inc.
About
Biogen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers products such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
